IE930976A1 - A method for the expression of genes under the control of¹the lac operator - Google Patents
A method for the expression of genes under the control of¹the lac operatorInfo
- Publication number
- IE930976A1 IE930976A1 IE930976A IE930976A IE930976A1 IE 930976 A1 IE930976 A1 IE 930976A1 IE 930976 A IE930976 A IE 930976A IE 930976 A IE930976 A IE 930976A IE 930976 A1 IE930976 A1 IE 930976A1
- Authority
- IE
- Ireland
- Prior art keywords
- expression
- galactose
- gal
- coli
- growth
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 34
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 33
- 229930182830 galactose Natural products 0.000 claims abstract description 46
- 241000588724 Escherichia coli Species 0.000 claims abstract description 26
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims abstract description 20
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims abstract description 20
- 230000012010 growth Effects 0.000 claims description 49
- 230000006698 induction Effects 0.000 claims description 32
- 239000002028 Biomass Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 101150096316 5 gene Proteins 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 abstract description 15
- 230000008569 process Effects 0.000 abstract description 15
- 210000004027 cell Anatomy 0.000 description 27
- 102000004169 proteins and genes Human genes 0.000 description 14
- 239000000411 inducer Substances 0.000 description 11
- 230000014616 translation Effects 0.000 description 10
- 230000035772 mutation Effects 0.000 description 9
- 238000001243 protein synthesis Methods 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 241000588915 Klebsiella aerogenes Species 0.000 description 6
- DLRVVLDZNNYCBX-CAPXFGMSSA-N allolactose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)O1 DLRVVLDZNNYCBX-CAPXFGMSSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 241000588748 Klebsiella Species 0.000 description 5
- 101710137500 T7 RNA polymerase Proteins 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 244000287680 Garcinia dulcis Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- 108010054278 Lac Repressors Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 108010034634 Repressor Proteins Proteins 0.000 description 2
- 102000009661 Repressor Proteins Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 108010082433 UDP-glucose-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- KDSPLKNONIUZSZ-HSUXUTPPSA-N (2r,4r,5r)-2,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@H](O)C[C@@H](O)C=O KDSPLKNONIUZSZ-HSUXUTPPSA-N 0.000 description 1
- VRYALKFFQXWPIH-HSUXUTPPSA-N 2-deoxy-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-HSUXUTPPSA-N 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 208000027472 Galactosemias Diseases 0.000 description 1
- 101100454318 Lactobacillus casei lacT gene Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 101150045500 galK gene Proteins 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229940021223 hypertonic solution Drugs 0.000 description 1
- 239000000815 hypotonic solution Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 238000001426 native polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE950847A IE71198B1 (en) | 1992-12-18 | 1993-12-17 | A method for the expression of genes under the control of the lac operator |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT251692A AT397812B (de) | 1992-12-18 | 1992-12-18 | Verfahren zur expression von genen unter kontrolle des lac-operators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IE930976A1 true IE930976A1 (en) | 1994-06-29 |
Family
ID=3535685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE930976A IE930976A1 (en) | 1992-12-18 | 1993-12-17 | A method for the expression of genes under the control of¹the lac operator |
Country Status (2)
| Country | Link |
|---|---|
| AT (1) | AT397812B (de) |
| IE (1) | IE930976A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7390645B2 (en) | 1997-11-20 | 2008-06-24 | William Marsh Rice University | Lactose repressor proteins with increased operator DNA binding affinity |
| AU1467399A (en) * | 1997-11-20 | 1999-06-15 | William Marsh Rice University | Lactose repressor proteins with altered ligand responsivity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3925550A1 (de) * | 1989-08-02 | 1991-02-07 | Behringwerke Ag | Optimierte fermentationsverfahren zur herstellung von fremdproteinen in e.coli |
-
1992
- 1992-12-18 AT AT251692A patent/AT397812B/de not_active IP Right Cessation
-
1993
- 1993-12-17 IE IE930976A patent/IE930976A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AT397812B (de) | 1994-07-25 |
| ATA251692A (de) | 1993-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5972663A (en) | Microorganisms and processes for the fermentative preparation of L-cysteine, L-cystine, N-acetylserine or thiazolidine derivatives | |
| EP0593792B2 (de) | Neuartiges L-threoninproduzierendes Mikrobakterium und eine Herstellungsmethode für L-Threonin | |
| EP2076601B1 (de) | Fermentative produktion von sialinsäure (neu5ac) mit hoher ausbeute | |
| KR101504485B1 (ko) | 제조 규모의 재조합 단백질 제조 방법 | |
| EP2825633B1 (de) | Verfahren zur züchtung von e. coli-zellen für hohe dichte | |
| TW200402471A (en) | Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family | |
| CN113122491B (zh) | 一种产n-乙酰神经氨酸的重组微生物及其应用 | |
| CN1900304A (zh) | 代谢控制的工程化 | |
| CN113652383B (zh) | 一种高产d-泛酸的基因工程菌及其应用 | |
| KR101584414B1 (ko) | 알칼리 공급원 | |
| CA2439096A1 (en) | Culture medium for enhanced heterologous protein expression | |
| CA1293217C (en) | Controlled growth rate fermentation | |
| IE930976A1 (en) | A method for the expression of genes under the control of¹the lac operator | |
| CN119120516A (zh) | 发酵生产维生素b5的工程菌及应用 | |
| Xie et al. | Production of 5-aminolevulinic acid by an Escherichia coli aminolevulinate dehydratase mutant that overproduces Rhodobacter sphaeroides aminolevulinate synthase | |
| JP7757412B2 (ja) | ヒドロキシチロソールの製造方法 | |
| IE71198B1 (en) | A method for the expression of genes under the control of the lac operator | |
| KR102226445B1 (ko) | Gaba 생산성이 향상된 대장균, 이의 제조방법 및 이를 이용한 gaba 생산방법 | |
| CN108611336A (zh) | 毕赤酵母诱导表达磷脂酶c的方法 | |
| Lang et al. | Multi-layered transcriptional and post-translational fine-tuning of metabolic pathways for overproduction of L-valine | |
| US20220403429A1 (en) | Optogenetic control of microbial co-culture populations | |
| TWI290175B (en) | A method for promoting growth of gene recombinant cell and enhancing production of target gene product | |
| CN108265061B (zh) | 一种大规模制备重组人成纤维细胞生长因子21(fgf21)的生产方法 | |
| JP4943678B2 (ja) | 細胞の脂肪酸組成を改変する方法およびその利用 | |
| KR102031886B1 (ko) | 신규한 프로모터 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM9A | Patent lapsed through non-payment of renewal fee |